Meanwhile, other trials, such as the American Z1041 trial,231 GeparQuattro study,235,236 and HannaH trial,237 also enrolled HER2 breast cancer with similar inclusion criteria as TECHNO to evaluate treatment with chemotherapy plus trastuzumab as concurrently or consequence regimens. Here, ERBB2 is linked to breast cancer.